1 May 2020

• US FDA issues an EUA for remdisivir enabling access for people hospitalized with severe COVID-19. Source
• Glenmark receives approval from the Drug Controller General of India (DCGI) to launch a clinical trial comparing favipiravir, a generic version of the antiviral drug Avigan, to standard of care among 150 people with moderate COVID-19. Source

Return to the timeline